Apollomics (APLM) Treasury Shares (2020 - 2023)
Apollomics (APLM) posted quarterly Treasury Shares of $68000.0 for Q4 2023, up 200.0% year-on-year from $22666.7 in Q4 2022, and up 200.0% on a QoQ basis from -$68000.0 in Q4 2022.
Apollomics (APLM) Treasury Shares (2020 - 2023) Analysis & Trends
Apollomics (APLM) has reported Treasury Shares for 4 consecutive years, with $68000.0 the latest figure, recorded in Q4 2023.
- Quarterly Treasury Shares rose 200.0% year-over-year to $68000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $68000.0 (up 200.0% YoY) and the FY2023 annual result came in at $68000.0, up 200.0% from the prior year.
- Treasury Shares advanced to $68000.0 in Q4 2023 per APLM's latest filing, from -$68000.0 in the prior quarter.
- Over the last five years, Treasury Shares for APLM reached as high as $26.4 million in Q4 2020 and fell as low as $4967.0 in Q4 2022.
- A 3-year average of $6.8 million and a median of $318809.5 in 2021 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2022 — Treasury Shares slumped 104.13% — and 2023, when it soared 200.0%.
- Year by year, Treasury Shares stood at $3.3 million in 2020, then sank by 49.35% to $1.6 million in 2021, then slumped by 104.13% to -$68000.0 in 2022, then surged by 200.0% to $68000.0 in 2023.
- According to Business Quant data, Treasury Shares over the past three periods registered $68000.0, -$68000.0, and $68000.0 for Q4 2023, Q4 2022, and Q2 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Apollomics | 2.66 Bn | 2.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 68,000.00 |
| Dec 31, 2023 | 68,000.00 |
| Dec 31, 2022 | 4,967.00 |
| Dec 31, 2022 | -68,000.00 |
| Dec 31, 2022 | -68,000.00 |
| Dec 31, 2022 | 4,967.00 |
| Jun 30, 2022 | 68,000.00 |
| Jun 30, 2022 | 68,000.00 |
| Jun 30, 2022 | 496,752.00 |
| Jun 30, 2022 | 496,752.00 |
| Dec 31, 2021 | 140,867.00 |
| Dec 31, 2021 | 1.65 Mn |
| Dec 31, 2021 | 1.65 Mn |
| Dec 31, 2021 | 140,867.00 |
| Dec 31, 2020 | 26.37 Mn |
| Dec 31, 2020 | 26.37 Mn |
| Dec 31, 2020 | 3.25 Mn |
| Dec 31, 2020 | 3.25 Mn |